Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 77.5 | 69.9 | 71.1 |
Revenue growth | | | | | | 10.9% | -1.6% | 0.6% |
Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 55.8 | 54.1 | 56.0 |
Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 21.7 | 15.8 | 15.0 |
Gross margin | | | | | | 27.9% | 22.6% | 21.2% |
Selling, general and administrative | 0.0 | 0.0 | 0.0 | 0.0 | | | | |
Sales and marketing | 0.0 | 0.0 | 0.0 | 0.0 | | 3.2 | 3.7 | 2.9 |
Research and development | | | | | | 16.2 | 16.5 | 16.0 |
General and administrative | 0.0 | 0.0 | 0.0 | 0.0 | 8.5 | 7.6 | 7.0 | 7.6 |
EBIT | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -5.5 | -11.4 | -11.5 |
EBIT margin | | | | | | -7.1% | -16.3% | -16.2% |
Pre-tax income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -5.0 | -11.3 | -13.2 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.7 | 0.0 | 0.1 |
Tax rate | | | | | | | 0.0% | |
Net income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -6.7 | -11.3 | -13.2 |
Net margin | | | | | | -8.7% | -16.1% | -18.6% |
|
Diluted EPS | | $0.00 | $0.00 | $0.00 | | ($0.18) | ($0.31) | ($0.37) |
Shares outstanding (diluted) | | 44.6 | 45.1 | 40.5 | | 36.4 | 36.2 | 36.0 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|